Cite Filings / DMRA / 0001193125-25-338281
Feed Companies Filings Check
Sign in
424B3

Prospectus

Damora Therapeutics, Inc. · Filed 2025-12-31 · Acc 0001193125-25-338281

Documents 1

  • 424B3 Prospectus , d98130d424b3.htm

Around this filing

  • 2026-01-06 4 Chief Executive Officer sold 700 shares at $21.38 ($14,966)
  • 2026-01-06 4 General Counsel sold 255 shares at $21.38 ($5,452)
  • 2026-01-06 4 Chief Financial Officer sold 135 shares at $21.41 ($2,890)
  • 2026-01-06 8-K Unregistered share sale · Executive or director change
  • 2026-01-02 S-8 Securities Offered to Employees in Benefit Plans
  • 2025-12-31 424B3 Prospectus
  • 2025-12-31 DEF 14A Proxy Statement

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d98130d424b3.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…